Two Sigma Investments
GRNA

Two Sigma Investments’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Two Sigma Investments’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,871
Closed -$68K – 2954
2022
Q2 		$68K Buy
+30,871
New +$214K ﹤0.01% 2318

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CGC
Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Two Sigma Investments's GRNA Position: Q3 2022 in Review

Two Sigma Investments sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2022, closing a stake of 30,871 shares — an estimated $68K sold.

Two Sigma Investments first reported a position in GRNA in Q2 2022 and held it in 1 quarter. The position peaked at $68K in Q2 2022. 57 funds tracked by Wall St. Rank hold GRNA as of Q3 2022.

  • Two Sigma Investments reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Investments sold 30,871 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2022, an estimated $68K.
  • Two Sigma Investments first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 1 quarter.
  • Two Sigma Investments's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $68K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.